Dear Sir,
Blood Services are uniquely positioned to take part in the management of the COVID-19 pandemic by providing ongoing snap-shots of the current SARS-CoV-2 immunity status of the ethnic populations they serve. This data can be used to model and monitor pandemic-immunization responses and endemic health care risks. Costs are an issue, and hospital blood typing laboratories are usually not equipped for large-scale infectious disease screening.



Stephen M. Henry - Centre for Kode Technology Innovation, School of Engineering, Computer and Mathematical Sciences, Faculty of Design and Creative Technologies, Auckland University of Technology, Auckland, New Zealand

Willy A. Flegel - Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, MD, United States of America

Christof Weinstock - German Red Cross Blood Service, Institute Ulm, and Department of Transfusion Medicine, Ulm University, Ulm, Germany

  • Abstract viewed - 330 times
  • pdf downloaded - 63 times